Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells

Liver inflammation represents a major clinical problem in a wide range of pathologies. Among the strategies to prevent liver failure, dexamethasone (DXM) has been widely used to suppress inflammatory responses. The use of nanocarriers for encapsulation and sustained release of glucocorticoids to liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Montano, Carolina, Rivero Berti, Ignacio, Gambaro, Rocío C., Limeres, María José, Svensson, Malin, Padula, Gisel, Chain, Cecilia Y., Cisneros, José Sebastián, Castro, Guillermo R., Grabbe, Stephan, Bros, Matthias, Gehring, Stephan, Islan, German A., Cacicedo, Maximiliano L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413549/
https://www.ncbi.nlm.nih.gov/pubmed/36015237
http://dx.doi.org/10.3390/pharmaceutics14081611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413549/
https://www.ncbi.nlm.nih.gov/pubmed/36015237
http://dx.doi.org/10.3390/pharmaceutics14081611

Ejemplares similares